Second Russian virus vaccine passes early trials - report

Early clinical trials of a second Russian coronavirus vaccine have proved successful, its developer said Thursday after Russia boasted of approving the world's first vaccine.

Russia's Vektor -- a top-secret state virology research center in Siberia -- said that early-stage trials were successful for its own experimental vaccine, named EpiVacCorona.